Endocyte, Inc. (ECYT) Tops Q4 Loss Views by 4c

Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• HomeTrust to acquire Blue Ridge Bankshares in $448M all-stock deal